Skip to main content
Top
Published in: BMC Psychiatry 1/2018

Open Access 01-12-2018 | Research article

Psychopathological and sociodemographic features in treatment-resistant unipolar depression versus bipolar depression: a comparative study

Authors: Nicolas A. Nuñez, Stefano Comai, Eduard Dumitrescu, Maykel F. Ghabrash, John Tabaka, Marie Saint-Laurent, Stephen Vida, Theodore Kolivakis, Allan Fielding, Nancy Low, Pablo Cervantes, Linda Booij, Gabriella Gobbi

Published in: BMC Psychiatry | Issue 1/2018

Login to get access

Abstract

Background

Some authors have hypothesized that Treatment-Resistant Unipolar Depression (TRD-UP) should be considered within the bipolar spectrum disorders and that hidden bipolarity may be a risk factor for TRD-UP. However, there are neither studies comparing clinical and sociodemographic data of patients with TRD-UP versus Bipolar (BP) disorders nor are there any examining differences versus Bipolar type I (BP-I) and Bipolar type II (BP-II).

Methods

Charts analysis was conducted on 194 patients followed at the Mood Disorders Clinic of the McGill University Health Center. Sociodemographic, clinical features and depression scales were collected from patients meeting DSM-IV criteria for TRD-UP (n = 100) and BP (n = 94). Binary logistic regression analysis was conducted to examine clinical predictors independently associated with the two disorders.

Results

Compared to BP, TRD-UP patients exhibited greater severity of depression, prevalence of anxiety and panic disorders, melancholic features, Cluster-C personality disorders, later onset of depression and fewer hospitalizations. Binary logistic regression indicated that higher comorbidity with anxiety disorders, higher depression scale scores and lower global assessment of functioning (GAF) scores, and lower number of hospitalizations and psychotherapies differentiated TRD-UP from BP patients. We also found that the rate of unemployment and the number of hospitalizations for depression was higher in BP-I than in BP-II, while the rate of suicide attempts was lower in BP-I than in BP-II depressed patients.

Conclusions

These results suggest that TRD-UP constitutes a distinct psychopathological condition and not necessarily a prodromal state of BP depression.
Literature
1.
go back to reference Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJ, Vos T, Whiteford HA. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013;10(11):e1001547.CrossRefPubMedPubMedCentral Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJ, Vos T, Whiteford HA. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013;10(11):e1001547.CrossRefPubMedPubMedCentral
2.
go back to reference Greden JF. The burden of disease for treatment-resistant depression. J Clin Psychiatry. 2001;62:26–31.PubMed Greden JF. The burden of disease for treatment-resistant depression. J Clin Psychiatry. 2001;62:26–31.PubMed
3.
go back to reference Kennedy N, Abbott R, Paykel E. Remission and recurrence of depression in the maintenance era: long-term outcome in a Cambridge cohort. Psychol Med. 2003;33(05):827–38.CrossRefPubMed Kennedy N, Abbott R, Paykel E. Remission and recurrence of depression in the maintenance era: long-term outcome in a Cambridge cohort. Psychol Med. 2003;33(05):827–38.CrossRefPubMed
4.
go back to reference Souery D, Papakostas GI, Trivedi MH. Treatment-resistant depression. J Clin Psychiatry. 2006;67:16.CrossRefPubMed Souery D, Papakostas GI, Trivedi MH. Treatment-resistant depression. J Clin Psychiatry. 2006;67:16.CrossRefPubMed
5.
go back to reference Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry. 2003;53(8):649–59.CrossRefPubMed Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry. 2003;53(8):649–59.CrossRefPubMed
6.
go back to reference Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, Ritz L, Nierenberg AA, Lebowitz BD, Biggs MM. Medication augmentation after the failure of SSRIs for depression. N Engl J Med. 2006;354(12):1243–52.CrossRefPubMed Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, Ritz L, Nierenberg AA, Lebowitz BD, Biggs MM. Medication augmentation after the failure of SSRIs for depression. N Engl J Med. 2006;354(12):1243–52.CrossRefPubMed
7.
go back to reference Lam RW, Kennedy SH, Grigoriadis S, McIntyre RS, Milev R, Ramasubbu R, Parikh SV, Patten SB, Ravindran AV. Canadian network for mood and anxiety treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults.: III. Pharmacotherapy. J Affect Disord. 2009;117:S26–43.CrossRefPubMed Lam RW, Kennedy SH, Grigoriadis S, McIntyre RS, Milev R, Ramasubbu R, Parikh SV, Patten SB, Ravindran AV. Canadian network for mood and anxiety treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults.: III. Pharmacotherapy. J Affect Disord. 2009;117:S26–43.CrossRefPubMed
8.
go back to reference Souery D, Amsterdam J, De Montigny C, Lecrubier Y, Montgomery S, Lipp O, Racagni G, Zohar J, Mendlewicz J. Treatment resistant depression: methodological overview and operational criteria. Eur Neuropsychopharmacol. 1999;9(1):83–91.CrossRefPubMed Souery D, Amsterdam J, De Montigny C, Lecrubier Y, Montgomery S, Lipp O, Racagni G, Zohar J, Mendlewicz J. Treatment resistant depression: methodological overview and operational criteria. Eur Neuropsychopharmacol. 1999;9(1):83–91.CrossRefPubMed
9.
go back to reference Berlim MT, Turecki G. Definition, assessment, and staging of treatment—resistant refractory major depression: a review of current concepts and methods. Can. J. Psychiatr. 2007;52(1):46–54.CrossRef Berlim MT, Turecki G. Definition, assessment, and staging of treatment—resistant refractory major depression: a review of current concepts and methods. Can. J. Psychiatr. 2007;52(1):46–54.CrossRef
10.
go back to reference Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR* D: implications for clinical practice. Am J Psychiatr. 2006;163(1):28–40.CrossRefPubMed Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR* D: implications for clinical practice. Am J Psychiatr. 2006;163(1):28–40.CrossRefPubMed
11.
go back to reference Fornaro M, Giosuè P. Current nosology of treatment resistant depression: a controversy resistant to revision. Clinical Practice & Epidemiology in Mental Health. 2010;6(1) Fornaro M, Giosuè P. Current nosology of treatment resistant depression: a controversy resistant to revision. Clinical Practice & Epidemiology in Mental Health. 2010;6(1)
12.
go back to reference Fornaro M, Giosuè P. Current nosology of treatment resistant depression: a controversy resistant to revision. 2010. Fornaro M, Giosuè P. Current nosology of treatment resistant depression: a controversy resistant to revision. 2010.
13.
go back to reference Souery D, Oswald P, Massat I, Bailer U, Bollen J, Demyttenaere K, Kasper S, Lecrubier Y, Montgomery S, Serretti A. Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. J Clin Psychiatry. 2007;68(7):1062–70.CrossRefPubMed Souery D, Oswald P, Massat I, Bailer U, Bollen J, Demyttenaere K, Kasper S, Lecrubier Y, Montgomery S, Serretti A. Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. J Clin Psychiatry. 2007;68(7):1062–70.CrossRefPubMed
14.
go back to reference Balestri M, Calati R, Souery D, Kautzky A, Kasper S, Montgomery S, Zohar J, Mendlewicz J, Serretti A. Socio-demographic and clinical predictors of treatment resistant depression: a prospective European multicenter study. J Affect Disord. 2016;189:224–32.CrossRefPubMed Balestri M, Calati R, Souery D, Kautzky A, Kasper S, Montgomery S, Zohar J, Mendlewicz J, Serretti A. Socio-demographic and clinical predictors of treatment resistant depression: a prospective European multicenter study. J Affect Disord. 2016;189:224–32.CrossRefPubMed
15.
go back to reference Dudek D, Rybakowski JK, Siwek M, Pawłowski T, Lojko D, Roczeń R, Kiejna A. Risk factors of treatment resistance in major depression: association with bipolarity. J Affect Disord. 2010;126(1):268–71.CrossRefPubMed Dudek D, Rybakowski JK, Siwek M, Pawłowski T, Lojko D, Roczeń R, Kiejna A. Risk factors of treatment resistance in major depression: association with bipolarity. J Affect Disord. 2010;126(1):268–71.CrossRefPubMed
16.
go back to reference Bennabi D, Aouizerate B, El-Hage W, Doumy O, Moliere F, Courtet P, Nieto I, Bellivier F, Bubrovsky M, Vaiva G, et al. Risk factors for treatment resistance in unipolar depression: a systematic review. J Affect Disord. 2015;171:137–41.CrossRefPubMed Bennabi D, Aouizerate B, El-Hage W, Doumy O, Moliere F, Courtet P, Nieto I, Bellivier F, Bubrovsky M, Vaiva G, et al. Risk factors for treatment resistance in unipolar depression: a systematic review. J Affect Disord. 2015;171:137–41.CrossRefPubMed
17.
go back to reference Gobbi G, Ghabrash MF, Nuñez N, Tabaka J, Di Sante J, Saint-Laurent M, Vida S, Kolivakis T, Low N, Cervantes P, Comai S. Antidepressant combination versus antidepressants plus second-generation antipsychotic augmentation in treatment-resistant unipolar depression. Int Clin Psychopharmacol. 2018;33(1):34–43. Gobbi G, Ghabrash MF, Nuñez N, Tabaka J, Di Sante J, Saint-Laurent M, Vida S, Kolivakis T, Low N, Cervantes P, Comai S. Antidepressant combination versus antidepressants plus second-generation antipsychotic augmentation in treatment-resistant unipolar depression. Int Clin Psychopharmacol. 2018;33(1):34–43.
18.
go back to reference Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW, Post RM, Berk M, Goodwin GM, Sachs GS. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatr. 2013;170(11):1249–62.CrossRefPubMedPubMedCentral Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW, Post RM, Berk M, Goodwin GM, Sachs GS. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatr. 2013;170(11):1249–62.CrossRefPubMedPubMedCentral
19.
go back to reference Ghaemi SN, Boiman EE, Goodwin FK. Diagnosing bipolar disorder and the effect of antidepressants: a naturalistic study. J Clin Psychiatry. 2000;61(10) Ghaemi SN, Boiman EE, Goodwin FK. Diagnosing bipolar disorder and the effect of antidepressants: a naturalistic study. J Clin Psychiatry. 2000;61(10)
20.
go back to reference Marchand WR. Recognizing and treating bipolar disorder. Hosp Physician. 2003;39(12):21–30. Marchand WR. Recognizing and treating bipolar disorder. Hosp Physician. 2003;39(12):21–30.
21.
go back to reference Geller B, Luby J. Child and adolescent bipolar disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry. 1997;36(9):1168–76.CrossRefPubMed Geller B, Luby J. Child and adolescent bipolar disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry. 1997;36(9):1168–76.CrossRefPubMed
22.
go back to reference Akiskal HS, Walker P, Puzantian VR, King D, Rosenthal TL, Dranon M. Bipolar outcome in the course of depressive illness. Phenomenologic, familial, and pharmacologic predictors J Affect Disord. 1983;5(2):115–28.CrossRefPubMed Akiskal HS, Walker P, Puzantian VR, King D, Rosenthal TL, Dranon M. Bipolar outcome in the course of depressive illness. Phenomenologic, familial, and pharmacologic predictors J Affect Disord. 1983;5(2):115–28.CrossRefPubMed
23.
go back to reference Benazzi F. Symptoms of depression as possible markers of bipolar II disorder. Prog Neuro-Psychopharmacol Biol Psychiatry. 2006;30(3):471–7.CrossRef Benazzi F. Symptoms of depression as possible markers of bipolar II disorder. Prog Neuro-Psychopharmacol Biol Psychiatry. 2006;30(3):471–7.CrossRef
24.
25.
go back to reference American Psychiatric Association: Diagnostic and statistical manual of mental disorders fourth edition text revision (DSM-IV-TR), vol. 4. Washington, DC; 2000. American Psychiatric Association: Diagnostic and statistical manual of mental disorders fourth edition text revision (DSM-IV-TR), vol. 4. Washington, DC; 2000.
26.
go back to reference First MB, Spitzer RL, Gibbon M, Williams JB. Structured clinical interview for DSM-IV-TR axis I disorders, research version, patient edition. In: SCID-I/P. 2002; First MB, Spitzer RL, Gibbon M, Williams JB. Structured clinical interview for DSM-IV-TR axis I disorders, research version, patient edition. In: SCID-I/P. 2002;
27.
go back to reference Fekadu WC, Poon KMBML, Cleare AJ. A multidimensional tool to quantify treatment resistance in depression: the Maudsley staging method. J. Clin. Psychiatry. 2009;70(2):177–84.CrossRefPubMed Fekadu WC, Poon KMBML, Cleare AJ. A multidimensional tool to quantify treatment resistance in depression: the Maudsley staging method. J. Clin. Psychiatry. 2009;70(2):177–84.CrossRefPubMed
28.
go back to reference Young R, Biggs J, Ziegler V, Meyer D. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133(5):429–35.CrossRefPubMed Young R, Biggs J, Ziegler V, Meyer D. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133(5):429–35.CrossRefPubMed
29.
go back to reference Zimmerman M, Martinez JH, Young D, Chelminski I, Dalrymple K. Severity classification on the Hamilton depression rating scale. J Affect Disord. 2013;150(2):384–8.CrossRefPubMed Zimmerman M, Martinez JH, Young D, Chelminski I, Dalrymple K. Severity classification on the Hamilton depression rating scale. J Affect Disord. 2013;150(2):384–8.CrossRefPubMed
30.
go back to reference Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134(4):382–9.CrossRefPubMed Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134(4):382–9.CrossRefPubMed
31.
go back to reference Guy W. Clinical global impression scale. The ECDEU assessment manual for psychopharmacology-revised volume DHEW Publ no. ADM. 1976;76(338):218–22. Guy W. Clinical global impression scale. The ECDEU assessment manual for psychopharmacology-revised volume DHEW Publ no. ADM. 1976;76(338):218–22.
32.
go back to reference Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R. The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54(5):573–83.CrossRefPubMed Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R. The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54(5):573–83.CrossRefPubMed
34.
go back to reference Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37(5):360–3.PubMed Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37(5):360–3.PubMed
35.
go back to reference Cohen J. Weighted kappa: nominal scale agreement provision for scaled disagreement or partial credit. Psychol Bull. 1968;70(4):213.CrossRefPubMed Cohen J. Weighted kappa: nominal scale agreement provision for scaled disagreement or partial credit. Psychol Bull. 1968;70(4):213.CrossRefPubMed
36.
go back to reference Mitchell PB, Goodwin GM, Johnson GF, Hirschfeld R. Diagnostic guidelines for bipolar depression: a probabilistic approach. Bipolar Disord. 2008;10(1p2):144–52.CrossRefPubMed Mitchell PB, Goodwin GM, Johnson GF, Hirschfeld R. Diagnostic guidelines for bipolar depression: a probabilistic approach. Bipolar Disord. 2008;10(1p2):144–52.CrossRefPubMed
37.
go back to reference Mitchell PB, Malhi GS. Bipolar depression: phenomenological overview and clinical characteristics. Bipolar Disord. 2004;6(6):530–9.CrossRefPubMed Mitchell PB, Malhi GS. Bipolar depression: phenomenological overview and clinical characteristics. Bipolar Disord. 2004;6(6):530–9.CrossRefPubMed
38.
go back to reference Vergunst FK, Fekadu A, Wooderson SC, Tunnard CS, Rane LJ, Markopoulou K, Cleare AJ. Longitudinal course of symptom severity and fluctuation in patients with treatment-resistant unipolar and bipolar depression. Psychiatry Res. 2013;207(3):143–9.CrossRefPubMed Vergunst FK, Fekadu A, Wooderson SC, Tunnard CS, Rane LJ, Markopoulou K, Cleare AJ. Longitudinal course of symptom severity and fluctuation in patients with treatment-resistant unipolar and bipolar depression. Psychiatry Res. 2013;207(3):143–9.CrossRefPubMed
39.
go back to reference Benazzi F. Depression with DSM-IV atypical features: a marker for bipolar II disorder. Eur Arch Psychiatry Clin Neurosci. 2000;250(1):53–5.CrossRefPubMed Benazzi F. Depression with DSM-IV atypical features: a marker for bipolar II disorder. Eur Arch Psychiatry Clin Neurosci. 2000;250(1):53–5.CrossRefPubMed
40.
go back to reference Zaninotto L, Souery D, Calati R, Sentissi O, Kasper S, Akimova E, Zohar J, Montgomery S, Mendlewicz J, Serretti A. Treatment resistance in severe unipolar depression: no association with psychotic or melancholic features. Ann Clin Psychiatry. 2013;25(2):97–106.PubMed Zaninotto L, Souery D, Calati R, Sentissi O, Kasper S, Akimova E, Zohar J, Montgomery S, Mendlewicz J, Serretti A. Treatment resistance in severe unipolar depression: no association with psychotic or melancholic features. Ann Clin Psychiatry. 2013;25(2):97–106.PubMed
41.
go back to reference Kornstein SG, Schneider RK. Clinical features of treatment-resistant depression. J Clin Psychiatry. 2001;62:18–25.PubMed Kornstein SG, Schneider RK. Clinical features of treatment-resistant depression. J Clin Psychiatry. 2001;62:18–25.PubMed
42.
go back to reference Friborg O, Martinsen EW, Martinussen M, Kaiser S, Øvergård KT, Rosenvinge JH. Comorbidity of personality disorders in mood disorders: a meta-analytic review of 122 studies from 1988 to 2010. J Affect Disord. 2014:152:1–11. Friborg O, Martinsen EW, Martinussen M, Kaiser S, Øvergård KT, Rosenvinge JH. Comorbidity of personality disorders in mood disorders: a meta-analytic review of 122 studies from 1988 to 2010. J Affect Disord. 2014:152:1–11.
43.
go back to reference Vieta E, Colom F, Corbella B, Martínez-Arán A, Reinares M, Benabarre A, Gasto C. Clinical correlates of psychiatric comorbidity in bipolar I patients. Bipolar Disord. 2001;3(5):253–8.CrossRefPubMed Vieta E, Colom F, Corbella B, Martínez-Arán A, Reinares M, Benabarre A, Gasto C. Clinical correlates of psychiatric comorbidity in bipolar I patients. Bipolar Disord. 2001;3(5):253–8.CrossRefPubMed
44.
go back to reference Strawn JR, Adler CM, McNamara RK, Welge JA, Bitter SM, Mills NP, Barzman DH, Cerullo MA, Chang KD, Strakowski SM. Antidepressant tolerability in anxious and depressed youth at high risk for bipolar disorder: a prospective naturalistic treatment study. Bipolar Disord. 2014;16(5):523–30.CrossRefPubMed Strawn JR, Adler CM, McNamara RK, Welge JA, Bitter SM, Mills NP, Barzman DH, Cerullo MA, Chang KD, Strakowski SM. Antidepressant tolerability in anxious and depressed youth at high risk for bipolar disorder: a prospective naturalistic treatment study. Bipolar Disord. 2014;16(5):523–30.CrossRefPubMed
45.
go back to reference Angst J, Sellaro R, Stassen HH, Gamma A. Diagnostic conversion from depression to bipolar disorders: results of a long-term prospective study of hospital admissions. J Affect Disord. 2005;84(2):149–57.CrossRefPubMed Angst J, Sellaro R, Stassen HH, Gamma A. Diagnostic conversion from depression to bipolar disorders: results of a long-term prospective study of hospital admissions. J Affect Disord. 2005;84(2):149–57.CrossRefPubMed
46.
47.
go back to reference Kessing L, Andersen P. Evidence for clinical progression of unipolar and bipolar disorders. Acta Psychiatr Scand. 2017;135(1):51–64.CrossRefPubMed Kessing L, Andersen P. Evidence for clinical progression of unipolar and bipolar disorders. Acta Psychiatr Scand. 2017;135(1):51–64.CrossRefPubMed
48.
go back to reference Cassano GB, Rucci P, Frank E, Fagiolini A, Dell'Osso L, Shear MK, Kupfer DJ. The mood spectrum in unipolar and bipolar disorder: arguments for a unitary approach. Am J Psychiatry. 2004;161(7):1264-9. Cassano GB, Rucci P, Frank E, Fagiolini A, Dell'Osso L, Shear MK, Kupfer DJ. The mood spectrum in unipolar and bipolar disorder: arguments for a unitary approach. Am J Psychiatry. 2004;161(7):1264-9.
49.
go back to reference Fagiolini A, Kupfer DJ. Is treatment-resistant depression a unique subtype of depression? Biol Psychiatry. 2003;53(8):640–8. Fagiolini A, Kupfer DJ. Is treatment-resistant depression a unique subtype of depression? Biol Psychiatry. 2003;53(8):640–8.
50.
go back to reference Schneider K. Die Schichtung des emotionalen Lebens und der Aufbau der Depressionszustände. Zeitschrift für die gesamte Neurologie und Psychiatrie. 1920;59(1):281–6. Schneider K. Die Schichtung des emotionalen Lebens und der Aufbau der Depressionszustände. Zeitschrift für die gesamte Neurologie und Psychiatrie. 1920;59(1):281–6.
51.
go back to reference Schneider K. Clinical psychopathology: Grune & Stratton; 1959. Schneider K. Clinical psychopathology: Grune & Stratton; 1959.
Metadata
Title
Psychopathological and sociodemographic features in treatment-resistant unipolar depression versus bipolar depression: a comparative study
Authors
Nicolas A. Nuñez
Stefano Comai
Eduard Dumitrescu
Maykel F. Ghabrash
John Tabaka
Marie Saint-Laurent
Stephen Vida
Theodore Kolivakis
Allan Fielding
Nancy Low
Pablo Cervantes
Linda Booij
Gabriella Gobbi
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2018
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-018-1641-y

Other articles of this Issue 1/2018

BMC Psychiatry 1/2018 Go to the issue